ReviewCurrent pediatrics reports2026
Generative Artificial Intelligence Use and Adolescent Mental Health.
Review in Current pediatrics reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Purpose of Review: To synthesize recent literature on the relationships between generative artificial intelligence (GenAI) use and adolescents' mental health, with particular attention to problematic use and psychiatric vulnerabilities. Recent Findings: Emerging evidence suggests associations between GenAI use and a range of adolescent mental health outcomes, including depression, anxiety, psychosis-related experiences, externalizing behaviors, eating disorder risk, and suicidality. Problematic patterns of use, including dependency and emotional reliance, may be particularly relevant among adolescents with preexisting psychiatric vulnerabilities. Current evidence suggests that these relationships may be bidirectional: psychological distress can motivate GenAI use for companionship, emotional support, or escape, while problematic use may reinforce maladaptive beliefs, displace real-world relationships, and amplify existing vulnerabilities. However, evidence remains predominantly cross-sectional, limiting causal inference. Summary: GenAI may interact with and amplify underlying psychiatric vulnerabilities during adolescence, highlighting the importance of understanding patterns and motivations of use. Pediatricians and other clinicians caring for adolescents could consider not only the frequency of GenAI use but also motivations for use, problematic dependency, and socioemotional reliance. Identifying high-risk usage patterns of GenAI through longitudinal research, particularly among youth with preexisting psychiatric risks, may inform the development of tailored screening, intervention, and prevention strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.